Health policy and third-generation oral contraceptives

Human Reproduction

Volumn 11, Issue 4, 1996, Pages 691-692

  Michaels, M Alex ^a   Norpoth, Thomas ^b  

^a WYETH AYERST RESEARCH   (United States)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CHEMICALLY INDUCED DISORDER; FEMALE; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; REPRODUCTION; REVIEW; THROMBOPHLEBITIS;

CONTRACEPTIVES, ORAL; FEMALE; HEALTH POLICY; HUMANS; REPRODUCTIVE MEDICINE; THROMBOPHLEBITIS;

EID: 0030124220     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019228     Document Type: Review

References (10)

1. Bloemenkamp, K.W.M., Rosendaal, F.R., Helmerhorst, F M. et al (1995) Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestogen. Lancet, 346, 1593-1596.
2. Farmer, R.D.T. and Preston, T.D. (1995) The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J. Obstet. Gynaecol., 15, 195-200.
3. Gerstman, B.B., Piper, J.M. Tomita, D.K. et al. (1991) Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am. J Epidemiol., 133, 32-37.
4. Jick, H., Jick, S S , Gurewich, V. et al. (1995) Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet, 346, 1589-1593.
5. Lewis, M.A., Spitzer, W.O., Heinemann, L.A.J. et al. (1996) Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Br. Med. J., 312, 88-90.
6. Royal College of General Practitioners (1978) Oral contraceptives, venous thrombosis, and varicose veins: Royal College of General Practitioners' Oral Contraception Study. J.R. Coll. Gen. Pract., 28, 393-399.
7. Spitzer, W O., Lewis, M.A., Heinemann, L.A.J. et al. (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders, an international case-control study. Br. Med. J., 312, 83-88.
8. Vessey, M.P. (1988) Epidemiological studies of lower dose oral contraceptives. Presented at the XII World Congress of Gynecology and Obstetrics. Rio de Janeiro, October 26, 1988.
9. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. (1995a) Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet, 346, 1575-1582.
10. World Health Organization Collaboration Study of Cardiovascular Disease and Steroid Hormone Contraception. (1995b) Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet, 346, 1582-1588.